Koers Guizhou Xinbang Pharmaceutical Co., Ltd.
Aandelen
002390
CNE100000NG5
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,02 CNY | -0,74% | +1,52% | -9,46% |
Omzet 2022 | 6,35 mld. 879 mln. 816 mln. | Omzet 2023 | 6,46 mld. 894 mln. 830 mln. | Marktkapitalisatie | 8,56 mld. 1,18 mld. 1,1 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 224 mln. 31,01 mln. 28,78 mln. | Nettowinst (verlies) 2023 | 287 mln. 39,73 mln. 36,88 mln. | EV/omzet 2022 | 1,52 x |
Nettoschuld 2022 | 493 mln. 68,3 mln. 63,41 mln. | Nettoschuld 2023 | 29,4 mln. 4,07 mln. 3,78 mln. | EV/omzet 2023 | 1,33 x |
K/w-verhouding 2022 |
39,2
x | K/w-verhouding 2023 |
29,6
x | Werknemers | 5.149 |
Dividendrendement 2022 |
1,28% | Dividendrendement 2023 |
1,35% | Vrij verhandelbaar | 52,21% |
1 dag | -0,74% | ||
1 week | +1,52% | ||
Lopende maand | +1,52% | ||
1 maand | +3,08% | ||
3 maanden | +1,26% | ||
6 maanden | -15,01% | ||
Lopend jaar | -9,46% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ling Zhong Kong
CEO | Chief Executive Officer | 56 | 01-01-00 |
Ya Yun Xiao
DFI | Director of Finance/CFO | 51 | 12-05-15 |
Chuan Chen
IRC | Investor Relations Contact | 55 | 25-03-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jin Hu
BRD | Director/Board Member | 48 | 11-02-17 |
Ling Zhong Kong
CEO | Chief Executive Officer | 56 | 01-01-00 |
Jie Qing Zhang
PRN | Corporate Officer/Principal | 49 | 17-02-12 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
10-05-24 | 4,02 | -0,74% | 14 200 600 |
09-05-24 | 4,05 | +0,50% | 16 342 110 |
08-05-24 | 4,03 | 0,00% | 16 471 850 |
07-05-24 | 4,03 | +0,25% | 16 464 210 |
slotkoers Shenzhen S.E., 10 mei 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-9,46% | 1,06 mld. | |
+40,09% | 6,16 mld. | |
-16,34% | 4,46 mld. | |
-7,11% | 3,27 mld. | |
+5,14% | 3,2 mld. | |
-0,18% | 2,6 mld. | |
+47,93% | 1,98 mld. | |
-7,15% | 1,7 mld. | |
+0,67% | 1,66 mld. | |
-8,73% | 1,61 mld. |